Real-time enrollment status for this antiphospholipid syndrome (aps) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:38 AM UTC
| NCT Number | NCT06371417 |
| Recruiting Status | Recruiting |
| Condition | Antiphospholipid Syndrome (APS) |
| Phase | Clinical Trial |
| Target Enrollment | 144 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Chugai Pharmaceutical |
| Last Updated on CT.gov | April 2, 2026 (Apr 2, 2026) |
As of July 13, 2026: Clinical trial NCT06371417 is currently recruiting participants. This clinical trial study for antiphospholipid syndrome (aps) is actively seeking new participants at 11 locations across the United States. The study is sponsored by Chugai Pharmaceutical. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06371417 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06371417 was last updated Apr 2, 2026 (April 2, 2026). HelloStudys verifies this status automatically.